A phase II trial of recombinant human parathyroid hormone (1-34)

Trial Profile

A phase II trial of recombinant human parathyroid hormone (1-34)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Oct 2015

At a glance

  • Drugs Teriparatide (Primary) ; Calcium carbonate; Elcatonin
  • Indications Male osteoporosis; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors Shanghai United Cell Biotechnology
  • Most Recent Events

    • 28 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top